Related by context. Frequent words. (Click for all words.) 64 active comparator 63 achieved statistical significance 62 plus prednisone 61 diabetic neuropathic pain 60 elagolix 60 DAVANAT 59 pharmacodynamic effects 59 peg IFN 59 Imprime PGG 59 alvimopan 58 plus methotrexate 58 plus dexamethasone 58 placebo controlled clinical 58 nab paclitaxel 58 tipranavir 58 pertuzumab 57 placebo controlled studies 57 BNC# 57 Pivotal Phase III 57 #mg dose [003] 57 AZX# 57 Phase 1b clinical 57 NGX# 57 mg BID 57 tocilizumab 57 limiting toxicity 57 mg QD 57 efficacy 56 phase IIa 56 CA4P 56 safinamide 56 ACTEMRA 56 HGS ETR1 56 plus gemcitabine 56 peginterferon alfa 2b 56 Amrubicin 56 6R BH4 56 SILENOR TM 56 valopicitabine 56 pharmacokinetic profiles 56 Navelbine 56 Neurodex 56 DOXIL 56 phase IIb 56 Cloretazine R VNP#M 56 dose limiting toxicities 56 pharmacokinetic studies 56 FOLFIRI 56 TORISEL 56 double blinded placebo 55 Secondary endpoints include 55 administered subcutaneously 55 MAP# 55 placebo controlled trials 55 ICA # 55 noninferiority 55 irbesartan 55 rHuPH# 55 aflibercept 55 clinical endpoints 55 Taxotere ® 55 febuxostat 55 confirmatory Phase III 55 achieve statistical significance 55 statistically significant p = 55 Fludara 55 chronic angina 55 tezampanel 55 Ostarine 55 cangrelor 55 vasomotor symptoms 55 tolerability 55 #mg dose [001] 55 secondary efficacy endpoints 55 Pirfenidone 55 Phase 1b trial 55 mycophenolate mofetil 55 mg dose 54 Phase 2a trial 54 Synavive 54 metastatic hormone refractory 54 Phenoptin 54 events SAEs 54 Tolerability 54 tamsulosin 54 degarelix 54 phase 2a 54 randomized controlled clinical trials 54 mg doses 54 XGEVA 54 KNS # 54 pregabalin 54 placebo p = 54 discontinuations due 54 statistically significant improvement 54 Empatic 54 azacitidine 54 talabostat 54 PROMACTA 54 virologic response 54 TELCYTA